Skip to main content
. 2019 Dec 27;9:20041. doi: 10.1038/s41598-019-56603-8

Table 2.

The average of tumour-to-kidneys absorbed dose ratios considering different combinations kon and koff, ligand amounts and λint.

KDa [nM] koffb[1/ min] konc[L/ nmol/min] Ligand amount [nmol] Tumour-to-kidneys absorbed dose ratio of…
Tumour 1 and 2 for λintd of… Tumour REST for λintd of…
0.01 [min−1] 0.001 [min−1] 0.0001 [min−1] 0.01 [min−1] 0.001 [min−1] 0.0001 [min−1]
0.01 0.0001 0.01 32 1.8 ± 1.3 2.3 ± 1.7 2.4 ± 1.7 1.3 ± 1.0 1.8 ± 1.4 2.2 ± 1.6
100 2.2 ± 1.6 3.1 ± 2.3 3.1 ± 2.2 1.7 ± 1.4 3.1 ± 2.2 3.7 ± 2.6
316 2.9 ± 2.1 3.5 ± 2.4 3.2 ± 2.1 2.7 ± 2.0 4.2 ± 2.8 4.2 ± 2.6
0.01 0.001 0.1 32 1.2 ± 0.9 2.2 ± 1.7 3.0 ± 2.3 0.8 ± 0.6 1.6 ± 1.4 2.7 ± 2.1
100 1.8 ± 1.4 3.1 ± 2.3 3.4 ± 2.4 1.3 ± 1.1 3.1 ± 2.2 4.2 ± 3.0
316 2.6 ± 1.9 3.4 ± 2.4 3.4 ± 2.3 2.3 ± 1.7 4.1 ± 2.8 4.6 ± 2.9
0.1 0.001 0.01 32 1.8 ± 1.3 2.6 ± 1.9 3.2 ± 2.3 1.4 ± 1.1 2.3 ± 1.7 3.6 ± 2.4
100 2.2 ± 1.7 3.4 ± 2.5 3.5 ± 2.4 1.8 ± 1.4 3.5 ± 2.5 4.7 ± 3.1
316 2.9 ± 2.1 3.6 ± 2.5 3.4 ± 2.3 2.7 ± 2.0 4.5 ± 3.0 4.8 ± 3.0
0.1 0.01 0.1 32 1.3 ± 1.0 2.8 ± 2.1 3.7 ± 2.6 0.9 ± 0.7 2.3 ± 1.8 4.2 ± 2.9
100 1.9 ± 1.4 3.5 ± 2.6 3.8 ± 2.6 1.4 ± 1.2 3.7 ± 2.7 5.1 ± 3.3
316 2.7 ± 1.9 3.7 ± 2.6 3.5 ± 2.4 2.4 ± 1.8 4.6 ± 3.1 5.0 ± 3.1
1 0.01 0.01 32 2.1 ± 1.6 3.4 ± 2.4 3.3 ± 2.2 1.7 ± 1.3 3.7 ± 2.5 4.3 ± 2.7
100 2.5 ± 1.9 3.7 ± 2.6 3.3 ± 2.2 2.1 ± 1.6 4.4 ± 3.0 4.6 ± 2.9
316 3.0 ± 2.2 3.7 ± 2.6 3.1 ± 2.0 3.0 ± 2.1 4.9 ± 3.2 4.4 ± 2.7
1 0.1 0.1 32 1.8 ± 1.4 3.5 ± 2.5 3.4 ± 2.3 1.4 ± 1.1 3.7 ± 2.6 4.4 ± 2.8
100 2.3 ± 1.7 3.8 ± 2.7 3.3 ± 2.3 1.9 ± 1.5 4.5 ± 3.1 4.7 ± 2.9
316 2.9 ± 2.1 3.8 ± 2.6 3.1 ± 2.0 2.8 ± 2.0 4.9 ± 3.2 4.4 ± 2.7

aKD = Dissociation constant (KD = koff/kon); bkoff = Dissociation rate; ckon = Association rate; dλint = Internalization rate. The values in bold are the maximum tumour-to-kidneys absorbed dose ratio.